Overview

India’s pharmaceutical industry stands at the crossroads of a period rich with opportunity and uncertainty as businesses are confronted by the need to generate growth in a mature, competitive market while faced with increasing pricing pressures, evolving government regulations and protectionist policies. As the world's third-largest pharmaceutical industry by volume, this sector has borne witness to a remarkable influx of private investment, particularly within the API (Active Pharmaceutical Ingredients) segment and the broader domain. With clear interest in revenue growth, trends toward deregulation and government incentives and policies (PLI, SPI, Bulk Drug Parks and PTUA Schemes), India is clearly looking at this sector as a core driver of growth.

India’s pharmaceutical industry stands at the crossroads of a period rich with opportunity and uncertainty as businesses are confronted by the need to generate growth in a mature, competitive market while faced with increasing pricing pressures, evolving government regulations and protectionist policies.

As the world’s third-largest pharmaceutical industry by volume, this sector has borne witness to a remarkable influx of private investment, particularly within the API (Active Pharmaceutical Ingredients) segment and the broader domain. With clear interest in revenue growth, trends toward deregulation and government incentives and policies (PLI, SPI, Bulk Drug Parks and PTUA Schemes), India is clearly looking at this sector as a core driver of growth.

ELP’s pharmaceutical offering includes a multi-disciplinary team of experts from its corporate, regulatory, international trade, tax, anti-trust, white collar crimes and disputes teams. Working with both domestic and multinational companies, we have a deep understanding of the legal and regulatory landscape governing the pharmaceutical industry in India, as well as the unique business and ethical considerations that come with this sector.

Our services include:

  • Support in leveraging ‘Make in India’ policies
  • Assistance in Green Field projects
  • Acquisition and development of real estate assets, including greenfield and brownfield facilities
  • Strategic M&A’s and Joint Ventures
  • Dispute resolution in every forum, including litigation and arbitration
  • Advisory on Merger Controls ; Anti -Competitive Agreements; Abuse of Dominant Position
  • Government Affairs and Regulatory
  • Tax Optimization, Disputes and Advocacy
  • End to end assistance on customs related issues
  • Advisory on BIS/Quality Controls
  • Advisory on Trade Advocacy/Trade Remedial/Sanctions
  • Adherence to ESG norms
  • White Collar Crimes/Forensic investigations/Criminal matters

Thought Leadership

Alerts & Updates 17th Jul 2024

Pharmaceutical Regulations: A move towards greater transparency and accountability

READ MORE

Alerts & Updates 16th Jul 2024

Strengthening of Export Regulations concerning Drugs in India

READ MORE

News & Media 4th Jun 2024

GST probe wing set to widen scrutiny of pharma companies

READ MORE

Alerts & Updates 29th Nov 2023

Delhi High Court Judgment in Bharat Serums – a relief to Drug Manufacturers

READ MORE

News & Media 27th Nov 2023

Proposed NPC Bill to promote innovation & research in pharmacy: Experts

READ MORE

Articles 18th Aug 2023

Quality controls standards and the EV charging ecosystem: All you need to know

READ MORE

Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

READ MORE

Alerts & Updates 6th Jul 2023

Whale Of A Tale: Tracing The Centre’s Recent Ban On 14 FDCs Approved Prior To 1988

READ MORE

Recent Matters

Assisted Piramal Enterprises in acquisition of 100% of shares in Hemmo Pharmaceuticals Private Limited by way of share transfer from...
READ MORE +

Assisted Piramal Enterprises in acquisition of 100% of shares in Hemmo Pharmaceuticals Private Limited by way of share transfer from the promoters of Hemmo.

Advised Somerset Indus Healthcare Fund on acquisition of a minority stake in Hexagon Nutrition Private Limited, a nutrition products company.

Advised Somerset Indus Healthcare Fund on acquisition of a minority stake in Hexagon Nutrition Private Limited, a nutrition products company.

Regularly rendering comprehensive indirect tax advisory and litigation services on a gamut of key issues and transactions for Johnson &...
READ MORE +

Regularly rendering comprehensive indirect tax advisory and litigation services on a gamut of key issues and transactions for Johnson & Johnson Pvt Limited.

Assisting and representing various Indian conglomerates and trade associations, across sectors, including pharmaceuticals, automotive and FMCG before the RoDTEP Committee.

Assisting and representing various Indian conglomerates and trade associations, across sectors, including pharmaceuticals, automotive and FMCG before the RoDTEP Committee.

Advising and representing a Group of pharmaceutical companies in relation to actions initiated by a cancer drug manufacturer, challenging the...
READ MORE +

Advising and representing a Group of pharmaceutical companies in relation to actions initiated by a cancer drug manufacturer, challenging the grant of marketing approval to bio-similar drugs.

Advised one of the world’s Leading pharmaceutical manufacturers in an investigation pending before the CCI on allegations of price fixing...
READ MORE +

Advised one of the world’s Leading pharmaceutical manufacturers in an investigation pending before the CCI on allegations of price fixing of certain drugs through co-marketing agreements with competitors.
View More

Related Practice Areas

Banking & Finance

Explore

Competition Law & Policy

Explore

Corporate & Commercial

Explore

Data Privacy

Explore

Financial Regulatory Practice & Litigation

Explore

Infrastructure, Projects & Energy

Explore

International Trade

Explore

Labour & Employment

Explore

Litigation, Arbitration & Alternate Dispute Resolution

Explore

Private Equity & Venture Capital

Explore

Real Estate

Explore

Regulatory & Compliance

Explore

Restructuring and Bankruptcy

Explore